AAAAAA
Results: 26-41/41
Authors:
Xu, SQ
El-Deiry, WS
Citation: Sq. Xu et Ws. El-deiry, p21(WAF1/CIP1) inhibits initiator caspase cleavage by TRAIL death receptorDR4, BIOC BIOP R, 269(1), 2000, pp. 179-190
Authors:
El-Deiry, WS
Citation: Ws. El-deiry, The TRAIL to an anticancer agent, DRUG RESIST, 2(2), 1999, pp. 79-80
Authors:
Mitchell, KO
El-Deiry, WS
Citation: Ko. Mitchell et Ws. El-deiry, Overexpression of c-Myc inhibits p(21WAF1/CIP1) expression and induces S-phase entry in 12-O-tetradecanoylphorbol-13-acetate (TPA)-sensitive human cancer cells, CELL GROWTH, 10(4), 1999, pp. 223-230
Authors:
Prabhu, NS
Somasundaram, K
Tian, H
Enders, GH
Satyamoorthy, K
Herlyn, M
El-Deiry, WS
Citation: Ns. Prabhu et al., The administration schedule of cyclin-dependent kinase inhibitor gene therapy and etoposide chemotherapy is a major determinant of cytotoxicity, INT J ONCOL, 15(2), 1999, pp. 209-216
Authors:
Meng, RD
Phillips, P
El-Deiry, WS
Citation: Rd. Meng et al., P53-independent increase in E2F-1 expression enhances the cytotoxic effects of etoposide and of adriamycin, INT J ONCOL, 14(1), 1999, pp. 5-14
Authors:
Wu, GS
Burns, TF
McDonald, ER
Meng, RD
Kao, G
Muschel, R
Yen, T
El-Deiry, WS
Citation: Gs. Wu et al., Induction of the TRAIL receptor KILLER/DR5 in p53-dependent apoptosis but not growth arrest, ONCOGENE, 18(47), 1999, pp. 6411-6418
Authors:
Somasundaram, K
MacLachlan, TK
Burns, TF
Sgagias, M
Cowan, KH
Weber, BL
El-Deiry, WS
Citation: K. Somasundaram et al., BRCA1 signals ARF-dependent stabilization and coactivation of p53, ONCOGENE, 18(47), 1999, pp. 6605-6614
Authors:
Sheikh, MS
Huang, Y
Fernandez-Salas, EA
El-Deiry, WS
Friess, H
Amundson, S
Yin, J
Meltzer, SJ
Holbrook, NJ
Fornace, AJ
Citation: Ms. Sheikh et al., The antiapoptotic decoy receptor TRID/TRAIL-R3 is a p53-regulated DNA damage-inducible gene that is overexpressed in primary tumors of the gastrointestinal tract, ONCOGENE, 18(28), 1999, pp. 4153-4159
Authors:
Sun, SY
Yue, P
Wu, GS
El-Deiry, WS
Shroot, B
Hong, WK
Lotan, R
Citation: Sy. Sun et al., Mechanisms of apoptosis induced by the synthetic retinoid CD437 in human non-small cell lung carcinoma cells, ONCOGENE, 18(14), 1999, pp. 2357-2365
Authors:
Mitra, J
Dai, CY
Somasundaram, K
El-Deiry, WS
Satyamoorthy, K
Herlyn, M
Enders, GH
Citation: J. Mitra et al., Induction of p21(WAF1/CIP1) and inhibition of Cdk2 mediated by the tumor suppressor p16(INK4a), MOL CELL B, 19(5), 1999, pp. 3916-3928
Authors:
Burns, TF
El-Deiry, WS
Citation: Tf. Burns et Ws. El-deiry, The p53 pathway and apoptosis, J CELL PHYS, 181(2), 1999, pp. 231-239
Authors:
Wu, GS
Burns, TF
Zhan, Y
Alnemri, ES
El-Deiry, WS
Citation: Gs. Wu et al., Molecular cloning and functional analysis of the mouse homologue of the KILLER/DR5 tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptor, CANCER RES, 59(12), 1999, pp. 2770-2775
Authors:
Sun, SY
Yue, P
Wu, GS
El-Deiry, WS
Shroot, B
Hong, WK
Lotan, R
Citation: Sy. Sun et al., Implication of p53 in growth arrest and apoptosis induced hy the syntheticretinoid CD437 in human lung cancer cells, CANCER RES, 59(12), 1999, pp. 2829-2833
Authors:
Song, SS
MacLachlan, TK
Meng, RD
El-Deiry, WS
Citation: Ss. Song et al., Comparative gene expression profiling in response to p53 in a human lung cancer cell line, BIOC BIOP R, 264(3), 1999, pp. 891-895
Authors:
El-Deiry, WS
Citation: Ws. El-deiry, The role of p53 in chemosensitivity, CANC DRUG, 5, 1999, pp. 37-52
Authors:
El-Deiry, WS
Citation: Ws. El-deiry, Regulation of p53 downstream genes, SEM CANC B, 8(5), 1998, pp. 345-357